Literature DB >> 18550009

Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies.

S Meenatchisundaram1, G Parameswari, A Michael, S Ramalingam.   

Abstract

Antivenom antibodies were raised in 24-week-old white leghorn chickens against hemotoxic venoms of Russell's viper and Saw-scaled viper snakes. Booster injections of increasing concentrations of venom were given at 14days of time interval to raise the antivenom level in egg yolk. Antibodies were extracted from immunized chicken egg yolk by Polson et al. (Polson A., Von Wechmar M.B., Van Regenmortel M.H.V. Isolation of viral IgY antibodies from yolks of immunized hens. Immunological Communications 1980; 9:475-493.) and further purified by DEAE cellulose ion exchange column chromatography, which gave pure (180-200kDa) specific antibodies against venom. High titre of more than 1:10,000 antibodies were detected by ELISA at the 135th day of observation. The lethal toxicity and various pharmacological activities like hemorrhagic activity, phospholipase activity, edema and procoagulant activities of venom were carried out by both in vivo and in vitro methods. The effectiveness of antivenom in neutralizing these effects was carried out involving pre-incubation type experiments. The median effective dose (ED50) for Russell's viper venom was 0.96mg/2LD50/18g mice and for Saw-scaled viper venom it was 1.28mg/2LD50/18g mice. One millilitre of specific antivenom was effective in neutralizing 0.110mg of Russell's viper and 0.137mg of Saw-scaled viper venoms respectively (PD50). Antivenom was effective in neutralization assays in a dose dependent manner. The results indicate that antibodies raised in chicken could effectively neutralize the pharmacological effects induced by venoms and chickens therefore present an alternative and cheaper source of specific antibody generation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550009     DOI: 10.1016/j.intimp.2008.03.017

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Authors:  Nicole Haese; Rebecca L Brocato; Thomas Henderson; Matthew L Nilles; Steve A Kwilas; Matthew D Josleyn; Christopher D Hammerbeck; James Schiltz; Michael Royals; John Ballantyne; Jay W Hooper; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

2.  Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.

Authors:  Ashley L Fink; Katherine L Williams; Eva Harris; Travis D Alvine; Thomas Henderson; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

3.  Preparation and neutralization efficacy of IgY antibodies raised against Deinagkistrodon acutus venom.

Authors:  Jinhua Liu; Qiyi He; Wenwen Wang; Bin Zhou; Bo Li; Yingfeng Zhang; Cong Luo; Diancheng Chen; Jia Tang; Xiaodong Yu
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-04-04

Review 4.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

5.  Coral snake antivenom produced in chickens (Gallus domesticus).

Authors:  Irma Aguilar; Elda E Sánchez; María E Girón; Amalid Estrella; Belsy Guerrero; F Alexis Rodriguez-Acosta
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.